Abstract:Glucocorticoids (GCs) are a group of steroid hormones secreted by the adrenal glands in circadian cycles, and the dysregulation of GC signaling has been suggested to cause metabolic syndrome. Even though prolonged GC exposure is associated with serious side effects such asmetabolic syndromeand central nervous system disorders, the use of GCs in anti-inflammatory and immunosuppressive therapies has been continuously rising. Meanwhile, the exact mechanisms by which GCs can influence the lipid metabolism as well as behavior and how they are affected by time remain unknown. In this study, the effects of two different long-term GC dosing regimens on lipid metabolism and behavior were investigated. Male Wistar rats received daily administrations of the GC dexamethasone sodium phosphate (DEX, 0.5 mg/kg body weight) at either ZT0 (Dex0) or ZT12 (Dex12). After 6 weeks of treatment, DEX-treated rats, especially those treated at ZT0, had higher hepatic lipid accumulation and serum triglyceride levels and less locomotor activity than did control rats. In addition, serum levels of corticosterone, 5-hydroxy tryptamine and norepinephrine were decreased in the Dex0 group but not in the Dex12 group compared to the control group. Furthermore, quantitative real-time polymerase chain reaction analysis indicated that the chronic administration of GCs at ZT0 upregulated genes related to glycolysis and lipid synthesis and downregulated genes related to fatty acid beta-oxidation in the liver more remarkably than administration at ZT12. Both DEX-treated groups displayed severely altered expression patterns of the core clock genes Bmal1 and Per2 in the liver and in fat. In addition, the expression of glutamate aspartate transporter, glial fibrillary acidic protein and glutamate transporter- 1, astrocyte-related genes important for maintaining nervous system functions, was drastically decreased in the hippocampus of DEX-treated rats, especially when DEX was given at ZT0. In conclusion, our findings confirm that the severity of side effects, indicated by altered lipid metabolism and behavioral activity, depends on the timing of GC administration and is associated with the degree of glucocorticoid receptor dysfunction after dosing at disparate time points.

Direct Effect of Glucocorticoids on Lipolysis in Adipocytes

Adipocyte-derived Periostin Mediates Glucocorticoid-Induced Hepatosteatosis in Mice

Glucocorticoids decrease thermogenic capacity and increase triacylglycerol synthesis by glycerokinase activation in the brown adipose tissue of rats

Glucocorticoids, Adipose Metabolism and Insulin Resistance

Stimulating Lipolysis in Subcutaneous Adipose Tissues by Chronic Dexamethasone Administration in Goats

Timing of glucocorticoid administration determines severity of lipid metabolism and behavioral effects in rats.

Upregulation of Hepatic CD36 Via Glucocorticoid Receptor Activation Contributes to Dexamethasone-Induced Liver Lipid Metabolism Disorder in Mice.

11Β-Hydroxysteroid Dehydrogenase Type 1 Shrna Ameliorates Glucocorticoid-Induced Insulin Resistance and Lipolysis in Mouse Abdominal Adipose Tissue.

Adipose Glucocorticoid Action Influences Whole‐body Metabolismviamodulation of Hepatic Insulin Action

11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes

Dexamethasone-Induced Adipose Tissue Redistribution and Metabolic Changes: Is Gene Expression the Main Factor? An Animal Model of Chronic Hypercortisolism

Adipocyte glucocorticoid receptor is important in lipolysis and insulin resistance due to exogenous steroids, but not insulin resistance caused by high fat feeding

Ectopic Lipid Deposition Mediates Insulin Resistance in Adipose Specific 11Β-Hydroxysteroid Dehydrogenase Type 1 Transgenic Mice.

Glucocorticoids promote hepatic cholestasis in mice by inhibiting the transcriptional activity of the farnesoid X receptor.

Effect of Omega-3 Rich High-Fat Diet on Markers of Tissue Lipid Metabolism in Glucocorticoid-Treated Mice

Forkhead Box A3 Mediates Glucocorticoid Receptor Function in Adipose Tissue.

Glucocorticoid modulates oxidative and thermogenic function of rat brown adipose tissue and human brown adipocytes

Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens

Glucocorticoids increase adipocytes in muscle by affecting IL‐4 regulated FAP activity

Dexamethasone Facilitates Lipid Accumulation in Chicken Skeletal Muscle.

Glucocorticoid Exerts Its Non-Genomic Effect on Ipsc by Activation of A Phospholipase C-Dependent Pathway in Prefrontal Cortex of Rats